1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
BioArctic AB (publ)

BioArctic AB (publ)

BRCTF
BioArctic AB (publ)US flagOther OTC
35.00
USD
- -
- -
3.11BMarket Cap

Total Valuation

BioArctic AB (publ) carries a market capitalization of 3.11B, placing it among publicly traded companies globally. Its enterprise value stands at 25.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.11B
Enterprise Value25.82B

Share Statistics

BioArctic AB (publ) currently has 88.72M shares outstanding.

Shares Outstanding88.72M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

BioArctic AB (publ) trades at a trailing price-to-earnings ratio of 130.41.

PE Ratio130.41
PS Ratio24.24
PB RatioN/A
P/TBV Ratio12.65
P/FCF Ratio22.20
P/OCF Ratio22.19

Enterprise Valuation

On an enterprise value basis, BioArctic AB (publ) trades at an EV/EBITDA multiple of 65.46 and an EV/FCF ratio of 20.40. The EV/Sales ratio of 22.51 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 65.46 provides insight into valuation relative to core operating earnings.

EV / Sales22.51
EV / EBITDA65.46
EV / EBIT65.46
EV / FCF20.40

Financial Position

BioArctic AB (publ) maintains a current ratio of 6.54, meaning it holds 6.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.85, indicating elevated leverage, while an interest coverage ratio of 16.30 demonstrates strong ability to service its debt obligations.

Current Ratio6.54
Quick Ratio5.12
Debt / Equity1.85
Debt / EBITDA0.10
Interest Coverage16.30

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)8.88
Return on Invested Capital (ROIC)9.62
Return on Capital Employed (ROCE)492.14
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, BioArctic AB (publ) has paid 200.49M in income taxes, reflecting an effective tax rate of 48.46.

Income Tax200.49M
Effective Tax Rate48.46

Stock Price Statistics

BioArctic AB (publ)'s stock has gained approximately 80.97208% over the past 52 weeks. The 50-day moving average sits at 34.39, while the 200-day moving average is 33.63.

Beta (5Y)N/A
52-Week Price Change80.97208%
50-Day Moving Average34.39
200-Day Moving Average33.63
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, BioArctic AB (publ) generated 1.15B in revenue and converted that into 213.24M in net income, yielding earnings per share of 2.41. EBITDA reached 394.35M, while operating income came in at 394.35M.

Revenue1.15B
Gross Profit1.08B
Operating Income394.35M
Pretax Income413.73M
Net Income213.24M
EBITDA394.35M
EBIT394.35M
Earnings Per Share (EPS)2.41

Balance Sheet

BioArctic AB (publ) holds 2.03B in cash and equivalents against 40.74M in total debt, resulting in a net debt position of -1.20B.

Cash & Cash Equivalents2.03B
Total Debt40.74M
Net Debt-1.20B
Equity (Book Value)N/A
Book Value Per ShareN/A
Working Capital2.20B

Cash Flow

BioArctic AB (publ) produced 1.25B in operating cash flow over the past twelve months.

Operating Cash Flow1.25B
Capital ExpendituresN/A
Free Cash Flow1.25B
FCF Per Share14.15

Margins

BioArctic AB (publ) operates with a gross margin of 94.13, reflecting its pricing power and cost economics. The operating margin of 34.38 and net profit margin of 18.59 provide insight into operational efficiency.

Gross Margin94.13
Operating Margin34.38
Pretax Margin36.07
Profit Margin18.59
EBITDA Margin34.38

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.09
FCF Yield4.50

Scores

BioArctic AB (publ) posts an Altman Z-Score of 36.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score36.57